ACT Capital Management’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.48M | Sell |
2,197,480
-90,720
| -4% | -$103K | 3.43% | 10 |
|
|
2022
Q2 | $3.36M | Sell |
2,288,200
-170,400
| -7% | -$251K | 4.7% | 7 |
|
|
2022
Q1 | $5.63M | Sell |
2,458,600
-24,900
| -1% | -$57K | 5.96% | 4 |
|
|
2021
Q4 | $6.83M | Buy |
2,483,500
+16,000
| +0.6% | +$44K | 4.94% | 4 |
|
|
2021
Q3 | $14.8M | Buy |
2,467,500
+5,000
| +0.2% | +$30K | 7.67% | 3 |
|
|
2021
Q2 | $12M | Buy |
+2,462,500
| New | +$12M | 6.16% | 4 |
|